| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print July 9, 2009
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




From the Center for Transplantation and Renal Research,* and the Gene Expression Laboratory,¶ the University of Sydney at Westmead Millennium Institute, Sydney; the Sydney Head & Neck Cancer Institute,
Sydney Cancer Center, Royal Prince Alfred Hospital and Dermatology Research Laboratories, and the Department of Endocrinology,
University of Sydney, Sydney; the Center for Kidney Research,
The Childrens Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia
Epithelial-mesenchymal transition (EMT) plays an important role in organ fibrosis, including that of the kidney. Loss of E-cadherin expression is a hallmark of EMT; however, whether the loss of E-cadherin is a consequence or a cause of EMT remains unknown, especially in the renal system. In this study, we show that transforming growth factor (TGF)-β1-induced EMT in renal tubular epithelial cells is dependent on proteolysis. Matrix metalloproteinase-mediated E-cadherin disruption led directly to tubular epithelial cell EMT via Slug. TGF-β1 induced the proteolytic shedding of E-cadherin, which caused the nuclear translocation of β-catenin, the transcriptional induction of Slug, and the repression of E-cadherin transcription in tubular epithelial cells. These findings reveal a direct role for E-cadherin and for matrix metalloproteinases in causing EMT downstream of TGF-β1 in fibrotic disease. Specific inhibition rather than activation of matrix metalloproteinases may offer a novel approach for treatment of fibrotic disease.
This article has been cited by other articles:
![]() |
Y. Liu New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis J. Am. Soc. Nephrol., February 1, 2010; 21(2): 212 - 222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |